Bio Protech Inc (199290)

KONEX

Currency in KRW

332

-63(-15.95%)

Closed·04/09

Fair Value

Unlock Value

Day's Range

332

400

52 wk Range

279

660

199290 Income Statement

Assess the Bio Protech income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 199290 net worth.

Period Ending:

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

Total Revenues

aa.aa

18,007.08

18,054.77

18,608.51

20,578.67

Total Revenues Growth

aa.aa

+6.78%

+0.26%

+3.07%

+10.59%

Cost Of Revenues

aa.aa

12,874.63

15,321.89

15,083.97

16,441.42

Gross Profit

aa.aa

5,132.46

2,732.88

3,524.54

4,137.25

Gross Profit Growth

aa.aa

+39.58%

-46.75%

+28.97%

+17.38%

Gross Profit Margin %

aa.aa

28.5%

15.14%

18.94%

20.1%

Other Operating Expenses, Total

aa.aa

3,058.95

3,315.82

2,628.49

2,866.44

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+26.54%	+8.4%	-20.73%	+9.05%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	270.14	211.2	26.48	11.5
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,697.61	2,985.2	2,630.32	2,775.27
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-212.71	-382.68	-496.22	-443.84

Operating Income

aa.aa

2,073.51

-582.94

896.05

1,270.81

Operating Income Growth

aa.aa

+64.62%

-128.11%

+253.71%

+41.82%

EBIT Margin %

aa.aa

11.51%

-3.23%

4.82%

6.18%

Net Interest Expenses

aa.aa

-643.81

-718.51

-859.25

-838.83

Net Interest Expenses Growth

aa.aa

-25.25%

-11.6%

-19.59%

+2.38%

Interest Expense, Total

aa.aa

-659.27

-729.37

-871.72

-855.59

Interest And Investment Income

aa.aa

15.46

10.86

12.47

16.76

Other Non Operating Expenses, Total

aa.aa

-228.77

-105.95

36.74

210.46

EBT, Excl. Unusual Items

aa.aa

1,200.93

-1,407.4

73.54

642.45

Gain (Loss) On Sale Of Assets

aa.aa

1.12

70.05

0.09

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

1,200.93

-1,406.28

143.59

552.54

EBT, Incl. Unusual Items Growth

aa.aa

+60.04%

-217.1%

+110.21%

+284.82%

EBT, Incl. Unusual Items Margin

aa.aa

6.67%

-7.79%

0.77%

2.69%

Income Tax Expense

aa.aa

80.78

13.07

Net Income to Company

aa.aa

1,120.15

-1,419.36

143.59

552.54

Minority Interest

aa.aa

Net Income

aa.aa

1,120.15

-1,419.36

143.59

552.54

Net Income Growth

aa.aa

+52.58%

-226.71%

+110.12%

+284.82%

Net Income Margin %

aa.aa

6.22%

-7.86%

0.77%

2.69%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,120.15

-1,419.36

143.59

552.54

Basic EPS - Continuing Operations

aa.aa

579

-915

199

Basic EPS - Continuing Operations Growth

aa.aa

+52.37%

-258.03%

+104.37%

+397.5%

Diluted EPS - Continuing Operations

aa.aa

298

-915

199

Diluted EPS - Continuing Operations Growth

aa.aa

+15.95%

-407.05%

+104.37%

+397.5%

Basic Weighted Average Shares Outstanding

aa.aa

1.93

1.55

3.59

2.78

Diluted Weighted Average Shares Outstanding

aa.aa

3.76

1.55

3.59

2.78

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

2,842.51

821.03

1,936.18

2,454.73

EBITDA Growth

aa.aa

+50.79%

-71.12%

+135.82%

+26.78%

EBITDA Margin %

aa.aa

15.79%

4.55%

10.4%

11.93%

EBIT

aa.aa

2,073.51

-582.94

896.05

1,270.81

* In Millions of KRW (except for per share items)

FAQ

What was Bio Protech’s revenue at year end?

At the end of the last reported fiscal year, Bio Protech (199290) recorded total revenue of 20,579 million KRW.

What was Bio Protech’s net income for the year?

For the full year, Bio Protech reported net income of 553 million KRW.

What was Bio Protech’s gross profit for the year?

Gross profit for the year was reported at 4,137 million KRW.

What was Bio Protech’s annual operating income?

For the full year, Bio Protech (199290) reported operating income of 1,271 million KRW.

S&P/TSX

36,513.80

-119.32

-0.33%

S&P/TSX 60

2,145.93

-8.12

-0.38%

US 30

53,232.10

-453.4

-0.84%

US 500

7,706.90

-40.7

-0.53%

S&P 500 VIX

14.53

+0.21

+1.47%

DAX

26,046.40

+43.08

+0.17%

Dollar Index

99.13

+0.250

+0.25%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	69.78	-1.09%	34.67M
Suncor Energy	93.14	-1.14%	10.13M
Enbridge	69.32	-0.55%	9.89M
Toronto Dominion Bank	168.24	-0.98%	2.88M
RBC	291.48	-0.30%	1.19M
TC Energy	86.53	-0.16%	3.83M
Canadian Imperial Bank	162.75	-0.15%	1.98M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
SQID Tech	0.01	+100.00%	326.67K
ePlay Digital	0.010	+100.00%	7.00K
LFNT Resources	0.20	+90.48%	17.50K
World Copper	0.1750	+84.21%	545.59K
Jura Energy	0.095	+72.73%	27.00K

Name	Last	Chg. %	Vol.
Pioneer Media Holdings	0.01	-100.00%	0.00
Global Health Clinics	0.055	-80.00%	500.00
Carson River Ventures	0.04	-50.00%	1.25K
Ramm Pharma	0.01	-50.00%	1.00K
Albert Labs International	0.005	-50.00%	1.00K
Syntheia	0.02	-50.00%	12.65K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Hut 8	129.430	+6.61%	602.27K
Celestica Inc.	432.45	+1.15%	246.53K
Bombardier Inc	315.120	+3.56%	271.25K
Canadian Imperial Bank	162.75	-0.15%	1.98M
Keel Infra	4.81	+3.89%	3.68M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa	33.12	+52.97%	50.66
Aaaaaaaa Aa Aaaaa	7.76	+50.81%	11.70
Aaaaaaaaaaaa Aaaaaa	9.06	+50.49%	13.63
Aaaaaa A	102.02	+46.55%	149.51
Aaaa A Aaaa Aa	16.31	+46.08%	23.83
A Aaaaaaaaaaa	125.26	+44.07%	180.46
Aa Aaaaaaa Aa	5.37	+43.97%	7.73

Name	Last	Upside	Fair Value
Aaaaaaaaaa	33.12	+52.97%	50.66
Aaaaaaaa Aa Aaaaa	7.76	+50.81%	11.70
Aaaaaaaaaaaa Aaaaaa	9.06	+50.49%	13.63
Aaaaaa A	102.02	+46.55%	149.51
Aaaa A Aaaa Aa	16.31	+46.08%	23.83
A Aaaaaaaaaaa	125.26	+44.07%	180.46
Aa Aaaaaaa Aa	5.37	+43.97%	7.73

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Bio Protech Inc (199290)

199290 Income Statement

FAQ

What was Bio Protech’s revenue at year end?

What was Bio Protech’s net income for the year?

What was Bio Protech’s gross profit for the year?

What was Bio Protech’s annual operating income?

Trending Stocks